JPS6147519B2 - - Google Patents

Info

Publication number
JPS6147519B2
JPS6147519B2 JP54016534A JP1653479A JPS6147519B2 JP S6147519 B2 JPS6147519 B2 JP S6147519B2 JP 54016534 A JP54016534 A JP 54016534A JP 1653479 A JP1653479 A JP 1653479A JP S6147519 B2 JPS6147519 B2 JP S6147519B2
Authority
JP
Japan
Prior art keywords
culture
medium
substance
mycelium
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54016534A
Other languages
Japanese (ja)
Other versions
JPS55108293A (en
Inventor
Hitoshi Ito
Keishiro Shimura
Sensuke Naruse
Inosuke Iwade
Toshuki Sai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP1653479A priority Critical patent/JPS55108293A/en
Publication of JPS55108293A publication Critical patent/JPS55108293A/en
Publication of JPS6147519B2 publication Critical patent/JPS6147519B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 本発明は抗腫瘍作用を有する蛋白多糖体類の製
造法に関する。詳しくは、ハラタケ属に属する新
種キノコの菌体を培養し得られた培養培地から抗
腫瘍作用を有する蛋白多糖体を製造する方法に関
するものである。 担子菌類より抗腫瘍性物質を製造する方法は従
来から数多く提案されており、担子菌の子実体を
原料として水系溶媒による抽出によつて抗腫瘍性
物質を製造することは例えば特公昭51−22042号
公報に記載されている。 本発明者等はさきにハラタケ属に属する新品種
キノコ、カワリハラタケ(Agaricus
heterosistes Heinem.et Gooss)の子実体より抗
腫瘍作用を有する蛋白多糖体を製造する方法(特
願昭53−149828)を提案したが、今回本菌を培地
に培養し該培養液に蓄積される蛋白多糖体を採取
しそれらの薬理作用について鋭意研究した結果、
子実体より得た物質よりさらに強い抗腫瘍作用を
有する物質を工業生産上有利に培養培地より製造
し得ることを見出し本発明を完成した。 本発明において用いられる担子菌はブラジルサ
ンパウロ州ピエターデ市効外で採取し、近時我国
で初めて栽培することに成功した未だ菌分類上、
未登録の新品種である。 この担子菌による子実体の栽培法については特
願昭52−54638明細書に記載されている。次に、
本発明で使用する新品種キノコ、カワリハラタケ
の菌学的性質を示す。 (1) 子実体 子実体の形状は、つり鐘状で傘の大きさは5
〜15cmであり、独特の香り有する。傘が開き胞
子が形成されるときにむらがあり、胞子形成が
遅れ黒化するのに時間がかかる。ひだを顕微鏡
で観察すると棍棒体、側糸が微弱である。 同属の公知のキノコに比べ形態的に柄は太く
て長く、胞子の黒変が遅い。また、香気が強
く、柄の肉は美味で甘いことが特徴としてあげ
られる。 (2) 麦芽汁寒天培地及びバレイシヨ・ブドウ糖寒
天培地(PD培地)上によく生育する。PD培地
上では白色の菌糸が発育し、培地を褐色に変化
させる。 (3) 菌糸体最適生育条件 PH=6.0〜6.5 28℃ (4) 菌糸体の生育の範囲 PH=4.0〜8.0 10〜33℃ (5) 子実体発生の温度範囲 20〜30℃
適温は24〜28℃ (6) 子実体形成に当り菌糸網を作る。 (7) 子実体形成に当り堆肥上に畝上覆土を行なう
ことにより多量発生する。 以上の菌学的性質を同属の公知のキノコ、例え
ば、はらたけ(Agricus campestris Fr.)と比
較した場合、柄が太く、胞子の黒変が遅い点が異
なり、また香気が強く、柄の肉が美味で甘い点が
他にはみられない特徴的な性質となつている。 これらの菌学的諸性質から、本担子菌はハラタ
ケ属(Agaricus)に属する新菌種であるものと
判定され、カワリハラタケ(Agaricus
heterosistes Heinem.et Gooss)と命名した。な
お、本菌は工業技術院微生物工業技術研究所に受
託番号微工研菌寄第4731号として寄託されてい
る。さらに上記担子菌の人工的あるいは自然的変
異株によつても本蛋白多糖体を製造することがで
きる。 本発明において使用する菌株の培養は、担子菌
の培養に通常用いられる固体培養法または液体培
養法のいずれでもよいが後者の方法が生産性の点
で好んで用いられる。 培養の培地としては菌の発育に必要な諸栄養が
含まれていればよく通常の培地処方でよい。即
ち、炭素源としては例えばグルコース、シユーク
ロース、マルトース、でんぷんなど資化し得る炭
素源であれば利用できる。窒素源としては例えば
硫安、硝安、硝酸ソーダ、尿素、など;天然の複
合栄養源としては例えばジヤガイモエキス、ニン
ジンエキス、麦芽エキス、ペプトン、V−8ジユ
ース、麹エキス、酵母エキス、酵母粉、タマネギ
エキス、コーンステイーブリカーなど、無機塩類
としては例えばリン酸、塩類、マグネシウム塩
類、カルシウム塩類、鉄塩類、カリ塩類その他の
無機塩類などが利用できる。この他に生長に必要
な微量元素、ビタミンなどは適宜添加してもよ
い。 培養は通常好気条件下がよく、例えば振とう培
養法あるいは通気撹拌培養法が用いられる。培養
温度は20〜37℃、好しくは30℃前後で培養するの
がよい。培養PHは3.0〜9.0、好しくは4.5〜7.0が
生育が良好である。培養日数は培養条件によつて
異なるが菌体糸の生育があればよく、通常は2〜
30日間、最大の菌糸体の生産される時期がよい。
通気撹拌培養では通気量0.1〜10VVM、撹拌速度
30〜800r.p.m.の範囲で行なうのがよい。 培養終了後培養液を遠心分離あるいは過して
菌糸体を除去し、培養液を得る。得られた培養
液はその中に有効成分を含有しそのままでも、
抗腫瘍性を示すが、そのままか、もしくは適宜濃
縮した後水可溶性有機溶媒あるいは各種の塩類を
加えることにより目的とする蛋白多糖体を沈澱物
として採取することができる。例えばアルコー
ル、アセトンなどの水可溶性有機溶媒あるいは各
種の塩類、例えば硫安、塩化カルシウムなどを加
えることにより日的物を沈澱させ過または遠心
分離した後アセトン、エーテルで洗滌乾燥すると
粉末状として目的物を得ることができる。 培養液から沈澱物を生じさせる前に必要に応
じて透析、限外過、ゲル過などにより低分子
物質を除去したり、活性炭、イオン交換処理など
により脱色、脱イオンを行なうこともできる。ま
た、得られた沈澱物も必要に応じて水などに再溶
解し上記処理を行なつてもよい。次いでアルコー
ルなどの水性溶媒にて再沈澱させる操作を繰り返
し実施することもできる。 このようにして得られた物質は淡褐色ないし灰
白色不定形の粉末であり、その1%水溶液はPH
6.0を示す。この物質について呈色反応を行なつ
たところ、アンスロン−硫酸反応、フエノール−
硫酸反応、キサントプロテイン反応及びフオリン
チオカルト反応がいずれも陽性であり、本発明物
質はこれらの諸反応から蛋白多糖体であると考え
られる。 本発明物質のその他の物理化学的性質の一例は
下記の通りである。 (1) 平均分子量 105〜107、セフアロース4Bを用いたゲル過
法によつて測定した。分子量の標準物質として
デキストランを用いた。 (2) 比旋光度(透析試料について) 〔α〕20 =+63゜(2.0重量/容量%水溶液) (3) 元素分析 N:1.6%、C:39.3%、H:6.5%、O:
52.6%精製の程度によつてN含量がやゝ変動す
る。 (4) 構成糖 本物質の1%水溶液に1Nとなるように硫酸
を加え、4時間、封管中100℃にて加水分解を
行ない炭酸バリウムにて中和後その上澄液につ
いてシリカゲルの一次元薄層クロマトグラフイ
ーを行なつた。展開溶媒はn−プロピルアルコ
ール:酢酸エチル:水(7:1:2)、検出は
ジフエニルアミン−アニリンによる発色によつ
て行つた。その結果Rf=0.34(ガラクトー
ス)、0.45(マンノース)の2種のスポツトを
検出した。 さらに先に得られた上澄液を乾固しトリメチ
ルシリル化した後ガスクロマトグラフイーにて
分析した結果、主要成分としてマンノースを、
微量成分としてグルコース、ガラクトース及び
リボースを確認した。 (5) アミノ酸 本物質を再蒸留塩酸に溶解し、ドライアイス
浴上で凍結減圧密封した後、110℃、22時間加
水分解する。これを乾固し、PH=2.2の緩衝液
に溶かしこれをアミノ酸アナライザーにより分
析した。その結果、アスパラギン酸、スレオニ
ン、セリン、グルタミン酸、プロリン、グリシ
ン、アラニン、シスチン、バリン、メチオニ
ン、イソロイシン、ロイシン、チロシン、フエ
ニルアラニン、γ−アミノ酪酸、ヒスチジン、
オルニチン、リジン、及びアルギニンを検出し
た。 (6) 溶解性 水、1N苛性ソーダ、1Nアンモニア水、1N塩
酸、1N硫酸及び蟻酸に可溶。アルコール、ア
セトン、酢酸エチル、エーテル、ベンゼン、酢
酸、ジメチルスルホキシド、ジメチルホルムア
ミド、アセトニトリル及びジオキサンには不
溶。 (7) 紫外線吸収スペクトル(第1図参照) 本物質の0.05%水溶液について測定した結果
200nm及び250nm近傍に吸収を有する。 (8) 赤外線吸収スペクトル(第2図参照) 3400(S)、2930(M)、1640(S)、1540
(W)、1400(W)、1050(S)、900(W)、800
(W)、570(W)の特徴的吸収(波数cm-1)を示
す。(KBr法による。) (9) 粘度(透析試料について) 2.0(重量/容量)%水溶液についてBL型粘
度計(東京計器製)を用い20℃で測定した結
果、3.8cpsであつた。 (10) 味およびにおい 本物質及びその水溶液は無味、無臭である。 (11) 分解点 一定の分解点、融点を示さない。強熱により
炭化する。 各種文献によると、例えば、Lentinus
edodes(Berg)Sing.由来の抗腫瘍多糖レンチ
ナンはβ(1→3)を主鎖とし、β(1→
6)、β(1→3)の分岐を有するグルカンで
あり、また、Schizophyllum commue由来の抗
腫瘍多糖SPG(Schizophyllan)もβ(1→
3)結合を基本とするグルカンである。これら
に対し、本蛋白多糖体は、マンナンを主体とし
ており、今まで発表されている抗腫瘍多糖と明
らかに異なり新規のものである。 上記のような物理的化学的特性を有する本発明
の蛋白多糖体は、顕著な抗腫瘍作用を有すると共
に(後記参考例参照)、免疫増強作用、インター
フエロン誘起作用、血管機能改善作用(例えば抗
高脂血症作用)、肝機能改善作用等も認められ、
極めて有用な物質である。 以下に実施例を挙げて本発明を具体的に説明す
る。 実施例 1 グルコース4g、酵母エキス4g、麦芽エキス
10g、及び水1からなるPH5.5の培地を120℃、
20分間滅菌し、寒天培地に培養したカワリハラタ
ケ菌糸体を接種し、30℃で30日間、時々撹拌しな
がら静置培養した。 グルコース20g、エビオス粉5g、消泡剤レオ
コン1705W(ライオン油脂社製商品名)20ppm及
び水1からなるPH5.0の本培養培地2.0を5
坂口フラスコに入れ120℃、20分間滅菌した。こ
れに上記前培養した培地200mlを接種し、培養温
度30℃で往復振とう機にて培養した。30日間培養
後培養を停止し、遠心分離により菌糸体を除去
し、得られた液をロータリーエバポレータで6
分の1まで濃縮し、これに等量のエタノールを加
え4℃で1昼夜放置、沈澱を生じさせた。遠心分
離で沈澱を集めアセトン次いでエーテルで洗滌
し、乾燥後培地1当り淡褐色粉末875mgを得
た。 実施例 2 グルコース20g、酵母エキス5g及び純水1
からなるPH5.0に調整した培地を三角フラスコに
入れ120℃、20分間滅菌した。これに寒天培地
(スラント)に培養したカワリハラタケ菌糸体を
接種し30℃で3週間静置培養した。 グルコース50g、エビオス粉10g、消泡剤レオ
コン20ppmを1の純水に溶解しPHを5.0に調整
して本培養培地とした。この培地7.0を10容
のジヤーフアーメンターに入れ、120℃、20分間
滅菌した。 これに上記の前培養した培地500mlを接種し、
培養温度30℃通気量0.5vvM、撹拌速度200〜
300rpmの条件にて培養した。10日間の培養後培
養を停止し過にて菌糸体を分離後さらに遠心分
離機にて10000r.p.mで15分間遠心分離して菌糸
体を除去した。得られた液6.0をロータリーエ
バポレーターにて500mlまで濃縮しエタノール500
mlを加え1昼夜4℃に放置して沈澱を生じさせ
た。 次いで固液分離し得られた沈澱物をアセトン、
エーテルで洗滌した後乾燥して7.5gの淡褐色粉
末を得た。これを純水に溶解し透析チユーブ(ユ
ニオンカーバイド社製ビスキングチユーブ)にて
純水に対して透析し、生じた沈澱物を遠心分離に
て除去後上澄液を凍結乾燥し6.0gの白色粉末を
得た。 参考例 1 ザルコーマ180腫瘍に対する効果 腫瘍接種24時間後から実施例2で得られた淡褐
色の蛋白多糖体(未透析物)を生理食塩水に溶解
させて1群11匹のマウス(Swiss albino mice)
の腹腔内に毎日1回10日間、所定量を投与した。
接種後14日、21日、28日及び35日に夫々肉腫の大
きさを測定し、その結果から抑制率を算出した。 それらの結果を第1表に示す。 【表】
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing protein polysaccharides having antitumor activity. Specifically, the present invention relates to a method for producing a protein polysaccharide having an antitumor effect from a culture medium obtained by culturing cells of a new mushroom belonging to the genus Agaricus. Many methods for producing antitumor substances from basidiomycetes have been proposed in the past, and for example, the production of antitumor substances by extraction with an aqueous solvent from the fruiting bodies of basidiomycetes was proposed in Japanese Patent Publication No. 51-22042. It is stated in the No. The present inventors first discovered a new variety of mushroom belonging to the genus Agaricus, Agaricus agaricus.
We have proposed a method for producing protein polysaccharides with antitumor activity from the fruiting bodies of Heinem. As a result of collecting protein polysaccharides and intensive research on their pharmacological effects,
The present invention was completed based on the discovery that a substance having a stronger antitumor effect than the substance obtained from the fruiting body can be produced from a culture medium, which is advantageous for industrial production. The basidiomycete used in the present invention was collected outside the city of Pietade, São Paulo, Brazil, and was recently successfully cultivated for the first time in Japan.
This is a new, unregistered variety. The method for cultivating fruiting bodies using this basidiomycete is described in Japanese Patent Application No. 52-54638. next,
The mycological properties of Kawariharatake, a new variety of mushroom used in the present invention, are shown. (1) Fruiting body The shape of the fruiting body is bell-shaped, and the size of the cap is 5.
It is ~15cm long and has a unique scent. When the cap opens, spores are formed unevenly, and spore formation is delayed and it takes time for the plant to turn black. When the folds are observed under a microscope, the club bodies and side threads are weak. Compared to other known mushrooms of the same genus, the stalk is thicker and longer, and the spores turn black later. It is also characterized by its strong aroma and the delicious and sweet meat of the stalk. (2) Grows well on wort agar medium and potato glucose agar medium (PD medium). White hyphae grow on the PD medium, turning the medium brown. (3) Optimal growth conditions for mycelium PH = 6.0-6.5 28℃ (4) Range of mycelium growth PH = 4.0-8.0 10-33℃ (5) Temperature range for fruiting body development 20-30℃
The optimum temperature is 24-28℃ (6) A mycelial network is formed during fruiting body formation. (7) A large amount is generated when the compost is covered with ridges of soil during the formation of fruiting bodies. When comparing the above mycological properties with known mushrooms of the same genus, such as Agricus campestris Fr., they differ in that the stalks are thicker and the spores turn black more slowly, and they are also more fragrant and the flesh of the stalks is different. It is delicious and sweet, which makes it unique and unique. Based on these mycological properties, this basidiomycete was determined to be a new fungal species belonging to the genus Agaricus, and is considered to be a new species belonging to the genus Agaricus.
heterosistes Heinem.et Gooss). This bacterium has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology under accession number 4731. Furthermore, the present protein polysaccharide can also be produced using artificial or natural mutant strains of the basidiomycete. The strain used in the present invention may be cultured by either a solid culture method or a liquid culture method commonly used for culturing basidiomycetes, but the latter method is preferably used in terms of productivity. The culture medium may be any conventional medium formulation as long as it contains the various nutrients necessary for the growth of the bacteria. That is, any carbon source that can be assimilated, such as glucose, sucrose, maltose, or starch, can be used as the carbon source. Examples of nitrogen sources include ammonium sulfate, ammonium nitrate, sodium nitrate, urea, etc.; examples of natural complex nutritional sources include potato extract, carrot extract, malt extract, peptone, V-8 youth, koji extract, yeast extract, yeast powder, and onion. Examples of inorganic salts that can be used include extracts, corn stave liquor, etc., such as phosphoric acid, salts, magnesium salts, calcium salts, iron salts, potassium salts, and other inorganic salts. In addition, trace elements, vitamins, etc. necessary for growth may be added as appropriate. Cultivation is usually carried out under aerobic conditions, such as a shaking culture method or an aerated agitation culture method. The culture temperature is preferably 20 to 37°C, preferably around 30°C. Growth is good when the culture pH is 3.0 to 9.0, preferably 4.5 to 7.0. The number of days for culturing varies depending on the culture conditions, but it is sufficient as long as there is growth of mycelium, and usually 2 to 3 days.
A good time is when maximum mycelium is produced for 30 days.
For aerated agitation culture, aeration volume is 0.1 to 10VVM, stirring speed
It is best to do this in the range of 30 to 800 rpm. After completion of the culture, the culture solution is centrifuged or filtered to remove mycelia and obtain a culture solution. The obtained culture solution contains active ingredients and can be used as is.
Although it exhibits antitumor properties, the desired protein polysaccharide can be collected as a precipitate either as is or by adding a water-soluble organic solvent or various salts after appropriate concentration. For example, by adding a water-soluble organic solvent such as alcohol or acetone, or various salts such as ammonium sulfate or calcium chloride, a daily substance is precipitated, filtered or centrifuged, washed with acetone or ether, and dried to form a powder. Obtainable. Before producing a precipitate from the culture solution, low-molecular substances can be removed by dialysis, ultrafiltration, gel filtration, etc., or decolorization and deionization can be carried out by activated carbon, ion exchange treatment, etc., as necessary. Further, the obtained precipitate may also be redissolved in water or the like and subjected to the above treatment, if necessary. Then, the operation of reprecipitating with an aqueous solvent such as alcohol can be repeated. The substance thus obtained is a pale brown to grayish white amorphous powder, and its 1% aqueous solution has a pH of
Shows 6.0. When color reactions were performed on this substance, anthrone-sulfuric acid reaction, phenol-
The sulfuric acid reaction, xanthoprotein reaction, and pholinthiocalt reaction were all positive, and the substance of the present invention is considered to be a protein polysaccharide based on these reactions. Examples of other physicochemical properties of the substance of the present invention are as follows. (1) Average molecular weight: 10 5 to 10 7 , measured by gel filtration method using Sepharose 4B. Dextran was used as a standard substance for molecular weight. (2) Specific optical rotation (for dialysis sample) [α] 20 D = +63° (2.0% weight/volume aqueous solution) (3) Elemental analysis N: 1.6%, C: 39.3%, H: 6.5%, O:
52.6%N content varies slightly depending on the degree of purification. (4) Constituent sugar Add sulfuric acid to 1N to a 1% aqueous solution of this substance, perform hydrolysis at 100℃ in a sealed tube for 4 hours, neutralize with barium carbonate, and use the supernatant as a primary silica gel. Original thin layer chromatography was performed. The developing solvent was n-propyl alcohol: ethyl acetate: water (7:1:2), and detection was performed by color development using diphenylamine-aniline. As a result, two types of spots with Rf = 0.34 (galactose) and 0.45 (mannose) were detected. Furthermore, the supernatant liquid obtained earlier was dried, trimethylsilylated, and then analyzed by gas chromatography. As a result, mannose was detected as the main component.
Glucose, galactose, and ribose were confirmed as trace components. (5) Amino acids Dissolve this substance in redistilled hydrochloric acid, freeze and seal on a dry ice bath under reduced pressure, and then hydrolyze at 110°C for 22 hours. This was dried, dissolved in a buffer solution with a pH of 2.2, and analyzed using an amino acid analyzer. As a result, aspartic acid, threonine, serine, glutamic acid, proline, glycine, alanine, cystine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine, γ-aminobutyric acid, histidine,
Ornithine, lysine, and arginine were detected. (6) Solubility Soluble in water, 1N caustic soda, 1N aqueous ammonia, 1N hydrochloric acid, 1N sulfuric acid and formic acid. Insoluble in alcohol, acetone, ethyl acetate, ether, benzene, acetic acid, dimethyl sulfoxide, dimethyl formamide, acetonitrile and dioxane. (7) Ultraviolet absorption spectrum (see Figure 1) Measurement results for a 0.05% aqueous solution of this substance
It has absorption near 200nm and 250nm. (8) Infrared absorption spectrum (see Figure 2) 3400 (S), 2930 (M), 1640 (S), 1540
(W), 1400 (W), 1050 (S), 900 (W), 800
(W), exhibits characteristic absorption (wavenumber cm -1 ) of 570 (W). (Based on the KBr method.) (9) Viscosity (for dialysis samples) As a result of measuring a 2.0 (weight/volume)% aqueous solution at 20°C using a BL type viscometer (manufactured by Tokyo Keiki), it was 3.8 cps. (10) Taste and odor This substance and its aqueous solution are tasteless and odorless. (11) Decomposition point Does not show a fixed decomposition point or melting point. Carbonizes on ignition. According to various literatures, for example, Lentinus
The antitumor polysaccharide lentinan derived from edodes (Berg) Sing. has β(1→3) as its main chain, and β(1→
6), is a glucan with β(1→3) branching, and antitumor polysaccharide SPG (Schizophyllan) derived from Schizophyllum commue also has β(1→3) branches.
3) It is a glucan based on bonds. On the other hand, the present protein polysaccharide is mainly mannan-based and is clearly different from the anti-tumor polysaccharides that have been published so far. The protein polysaccharide of the present invention having the above-mentioned physicochemical properties has a remarkable antitumor effect (see reference examples below), and also has an immune-enhancing effect, an interferon-inducing effect, and a vascular function-improving effect (for example, an anti-tumor effect). Hyperlipidemic effect), liver function improving effect, etc. are also observed.
It is an extremely useful substance. The present invention will be specifically described below with reference to Examples. Example 1 Glucose 4g, yeast extract 4g, malt extract
A PH5.5 medium consisting of 10g of water and 1 part of water was heated at 120°C.
After sterilization for 20 minutes, the agar medium was inoculated with the cultivated Kawariharatake mycelium, which was then statically cultured at 30°C for 30 days with occasional stirring. 5 g of main culture medium 2.0 with a pH of 5.0 consisting of 20 g of glucose, 5 g of Ebios powder, 20 ppm of antifoaming agent Rheocon 1705W (product name manufactured by Lion Oil Co., Ltd.), and 1 part of water.
It was placed in a Sakaguchi flask and sterilized at 120°C for 20 minutes. This was inoculated with 200 ml of the above precultured medium, and cultured at a culture temperature of 30°C using a reciprocating shaker. After culturing for 30 days, the culture was stopped, the mycelium was removed by centrifugation, and the resulting liquid was purified using a rotary evaporator for 6 days.
The mixture was concentrated to one-fold, an equal amount of ethanol was added thereto, and the mixture was left standing at 4°C for 1 day to form a precipitate. The precipitate was collected by centrifugation, washed with acetone and then with ether, and after drying, 875 mg of light brown powder was obtained per medium. Example 2 Glucose 20g, yeast extract 5g and pure water 1
A culture medium adjusted to pH 5.0 consisting of was placed in an Erlenmeyer flask and sterilized at 120°C for 20 minutes. This was inoculated with Kawariharatake mycelium cultured on an agar medium (slant) and cultured stationary at 30°C for 3 weeks. A main culture medium was prepared by dissolving 50 g of glucose, 10 g of Ebios powder, and 20 ppm of the antifoaming agent Rheocon in 1 part pure water and adjusting the pH to 5.0. This medium 7.0 was placed in a 10 volume jar fermenter and sterilized at 120°C for 20 minutes. Inoculate this with 500 ml of the above pre-cultured medium,
Culture temperature: 30℃, aeration volume: 0.5vvM, stirring speed: 200~
Culture was performed at 300 rpm. After 10 days of culture, the culture was stopped and the mycelium was separated, followed by further centrifugation at 10,000 rpm for 15 minutes using a centrifuge to remove the mycelium. Concentrate the obtained liquid 6.0 to 500 ml using a rotary evaporator and add 500 ml of ethanol.
ml was added and left at 4°C for one day and night to form a precipitate. Next, the precipitate obtained by solid-liquid separation was mixed with acetone,
After washing with ether and drying, 7.5 g of light brown powder was obtained. This was dissolved in pure water and dialyzed against pure water using a dialysis tube (Union Carbide Visking tube). The resulting precipitate was removed by centrifugation, and the supernatant was lyophilized to yield 6.0 g of white. A powder was obtained. Reference Example 1 Effect on Sarcoma 180 Tumor 24 hours after tumor inoculation, the pale brown protein polysaccharide (undialyzed) obtained in Example 2 was dissolved in physiological saline, and 11 mice per group (Swiss albino mice) were dissolved. )
The prescribed amount was administered intraperitoneally once daily for 10 days.
The size of the sarcoma was measured on the 14th, 21st, 28th, and 35th after inoculation, and the inhibition rate was calculated from the results. The results are shown in Table 1. 【table】

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明により得られた蛋白多糖体の紫
外線吸収スペクトルであり、第2図はその赤外線
吸収スペクトルである。
FIG. 1 shows the ultraviolet absorption spectrum of the protein polysaccharide obtained according to the present invention, and FIG. 2 shows its infrared absorption spectrum.

Claims (1)

【特許請求の範囲】[Claims] 1 ハラタケ属に属するカワリハラタケを培養
し、得られる培養液から蛋白多糖体を採取する
ことを特徴とする蛋白多糖体の製造方法。
1. A method for producing a protein polysaccharide, which comprises culturing Kawariharatake belonging to the genus Agaricus and collecting the protein polysaccharide from the resulting culture solution.
JP1653479A 1979-02-15 1979-02-15 Production of proteopolysaccharide with antitumorigenic activity Granted JPS55108293A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1653479A JPS55108293A (en) 1979-02-15 1979-02-15 Production of proteopolysaccharide with antitumorigenic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1653479A JPS55108293A (en) 1979-02-15 1979-02-15 Production of proteopolysaccharide with antitumorigenic activity

Publications (2)

Publication Number Publication Date
JPS55108293A JPS55108293A (en) 1980-08-20
JPS6147519B2 true JPS6147519B2 (en) 1986-10-20

Family

ID=11918924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1653479A Granted JPS55108293A (en) 1979-02-15 1979-02-15 Production of proteopolysaccharide with antitumorigenic activity

Country Status (1)

Country Link
JP (1) JPS55108293A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512675B1 (en) * 1981-09-17 1987-07-17 Viaud Henri HYDROLAT OF AGARICUS BIOSPORUS AND CAMPESTER
JPS6466127A (en) * 1987-09-07 1989-03-13 Nichirei Kk Antitumor agent
JPH0278630A (en) * 1988-09-14 1990-03-19 Nichirei Corp Antitumor agent

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244636A (en) * 1975-10-06 1977-04-07 Minolta Camera Co Ltd Zoom lens barrel with a macro shooting mechanism

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244636A (en) * 1975-10-06 1977-04-07 Minolta Camera Co Ltd Zoom lens barrel with a macro shooting mechanism

Also Published As

Publication number Publication date
JPS55108293A (en) 1980-08-20

Similar Documents

Publication Publication Date Title
FI110324B (en) New polysaccharides and their production
KR870001814B1 (en) Process for preparing high molecular waight beta-1,3-glucan
WO2001002597A1 (en) Process for the preparation of the polysaccharides k4 and k5 from escherichia coli
JPH09238650A (en) Food material containing large amount of gamma-aminobutyric acid and production of the same
JPS6147519B2 (en)
JPH07119243B2 (en) β-glucan and method for producing the same
JPS6147518B2 (en)
JPS608797B2 (en) Polysaccharide M-30-C
US4177108A (en) Process for producing emitanin
JPH0372084B2 (en)
US4370416A (en) Hydroxy-cinnamic acid ester hydrolase and process for producing same
US6197571B1 (en) Protein polysaccharide 0041
JPS6327484A (en) Bisucaberin and production thereof
JP3731010B2 (en) Production method of polysaccharides
JPS6359679B2 (en)
JPH0632742A (en) Production of calcium ion solubilization agent
JPS58121798A (en) Polysaccharide mp-67 and its production
EP0296965B1 (en) Fermentation process for the preparation of a polysaccharide such as xanthan
JPS61101501A (en) Carcinostatic polysaccharide and its production
JPS5836395A (en) Preparation of polysaccharide
KR100470609B1 (en) A method for preventing of turbid of bamboo-shoot by using Chitosan produced from fungus
JPS597317B2 (en) Polysaccharide AX
JPH0240299B2 (en)
KR100566938B1 (en) Process for preparing crude peptide from amyda japonica
CN113502314A (en) Method for preparing yeast active polypeptide by enzymolysis of compound enzyme method